Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
Search for gunman who shot 2 people. The latest from Granville County police on the manhunt for a suspect
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Seagen Inc
(NQ:
SGEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Seagen Inc
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
3 Steal-of-a-Deal Stocks to Snap Up Right Now
February 26, 2024
Here are three steal-of-a-deal stocks that offer meaningful upside for investors looking for stocks that are on sale now.
Via
InvestorPlace
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
Pfizer Inc (NYSE: PFE) is among the many pharmaceutical companies that turned to oncology in response to sinking demand for its COVID-19 products and near patent expiration dates for its several...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Get Rich Quick with These 7 Growth Stocks to Buy Now
February 20, 2024
Here are seven growth stocks to buy that will let you know by their price action if the current bull market is ready to expand.
Via
InvestorPlace
7 Dividend Stocks to Buy at a 52-Week Low
February 12, 2024
Each of these dividend stocks has been down sharply in the last 12 months but has fundamental reasons that support a turnaround.
Via
InvestorPlace
Pfizer’s 2024 Comeback: A Dividend Gem in the Pharma Market
February 01, 2024
Pfizer is in Wall Street's doghouse, but don't despair. At its current price, value seekers ought to relish the opportunity to buy PFE stock.
Via
InvestorPlace
Looking Into Seagen's Recent Short Interest
December 13, 2023
Via
Benzinga
What the Options Market Tells Us About Seagen
December 11, 2023
Via
Benzinga
$100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
December 07, 2023
Via
Benzinga
3 Pharma Stocks Could Be the Pills Your Portfolio Needs
January 18, 2024
These large-cap pharma stocks offer growth and value with existing medicines, deep pipelines and reasonable valuations.
Via
InvestorPlace
How To Earn $500 A Month From Pfizer Stock
January 02, 2024
Pfizer Inc. (NYSE: PFE) shares closed almost flat on Friday, but lost around 44% during 2023.
Via
Benzinga
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.
Via
Benzinga
3 Stocks That Are About to Get Absolutely Crushed
December 14, 2023
These are a few different companies that are experiencing difficult times and that are expected to keep falling.
Via
InvestorPlace
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,600 Today
November 20, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Seagen Stock In The Last 15 Years
November 03, 2023
Via
Benzinga
Pfizer's 2030 Vision Bolstered By Seagen Deal, Analyst Cuts Price Target Amid Conservative 2024 Forecast
December 14, 2023
Truist Securities analyst Robyn Karnauskas reiterated a Buy rating on Pfizer, Inc. (NYSE: PFE),
Via
Benzinga
Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?
December 14, 2023
Pfizer recently outlined expectations for 2024 results in light of an upcoming $43 billion acquisition of Seagen.
Via
The Motley Fool
3 Sleepy Stocks Ready to Wake up in 2024
December 13, 2023
Strong projected earnings growth makes these three stocks strong candidates for exceptional growth in 2024.
Via
InvestorPlace
Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades'
December 13, 2023
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Shake Shack Inc (NYSE: SHAK)
Via
Benzinga
Pfizer Stock Tumble Steepens As Seagen Guidance Update Disappoints
December 13, 2023
Pfizer's updated 2024 revenue figures, including Seagen, undercut the consensus target.
Via
Investor's Business Daily
Why Is US Pharma Giant Pfizer Stock Trading Lower Today?
December 13, 2023
Pfizer Inc (NYSE: PFE) provided its full-year 2024 guidance, which includes the expected financial impact from the Seagen Inc (NASDAQ: SGEN) transaction.
Via
Benzinga
Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition
December 12, 2023
Pfizer Inc (NYSE: PFE)
Via
Benzinga
Bristol Myers Squibb Further Diversifies Oncology Portfolio With Mega $8.4B Deal
December 12, 2023
SystImmune and Bristol Myers Squibb & Co (NYSE: BMY)
Via
Benzinga
3 Blue-Chip Stocks Set to Make a Comeback in 2024
December 08, 2023
These are the blue-chip stocks to buy as they represent quality companies with a steady growth outlook and promising cash flow growth.
Via
InvestorPlace
ImmunoGen Stock Nearly Doubled On Thursday: What Happened?
November 30, 2023
Shares of ImmunoGen Inc. close to doubled this morning after AbbVie Inc. said it will buy the cancer therapies company for $10.1 billion.
Via
Talk Markets
Billionaire Favorites: 3 Ultra-High Yield Stocks the Elite Love
November 30, 2023
Buying stocks simple for their high dividend yields is risky but these are three stocks the elite love regardless.
Via
InvestorPlace
The 7 Most Undervalued Sleeper Stocks to Buy Now: November 2023
November 19, 2023
Here are just a few of the most undervalued sleeper stocks investors may want to consider heading into the new year.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
November 10, 2023
Via
Benzinga
BioNTech Stock Surges On Surprise Profit, Strong Sales. But Report Has Downside.
November 06, 2023
The company was expected to report a third-quarter loss and plummeting sales.
Via
Investor's Business Daily
This Is The 'Only Solar Stock' Jim Cramer Is Recommending 'Because It's A Pure Play'
November 06, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said DocuSign, Inc.
Via
Benzinga
CPRI, SGEN, VMW: Why These 3 Stocks Are on the Tip of Bill Gross’ Tongue
November 05, 2023
Bill Gross, the Bond King, is wading into the world of equity arbitrage with these three stocks - but are they worth the risk for investors?
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.